Myxoid liposarcoma: it's a hippo's world
Abstract Fused in sarcoma: DNA damage‐inducible transcript 3 protein (FUS:DDIT3) is a chimeric fusion oncoprotein present in 90% of human myxoid liposarcomas (MLS). The study by Trautmann et al in this issue of EMBO Molecular Medicine utilizes a drop‐out RNAi screen to establish hyperactive Yes‐asso...
Saved in:
| Main Authors: | Carla Regina, Simone Hettmer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2019-04-01
|
| Series: | EMBO Molecular Medicine |
| Online Access: | https://doi.org/10.15252/emmm.201910470 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GENETIC POLYMORPHISM OF RETROPERITONEAL MYXOID LIPOSARCOMA
by: A. Yu. Volkov, et al.
Published: (2020-07-01) -
Requirement for YAP1 signaling in myxoid liposarcoma
by: Marcel Trautmann, et al.
Published: (2019-03-01) -
Radiographic and pathologic response of myxoid liposarcoma treated with preoperative radiotherapy
by: Gao Robert W, et al.
Published: (2025-06-01) -
THE PROGNOSTIC SIGNIFICANCE OF MYXOID MATRIX IN RETROPERITONEAL WELL-DIFFERENTIATED LIPOSARCOMA
by: A. Yu. Volkov, et al.
Published: (2021-03-01) -
Recurrent Myxoid Liposarcoma of the Upper Thoracic Spine: A Case Report
by: Huaitai Lin, et al.
Published: (2025-01-01)